All Stories

  1. Developing reporting checklist items from systematic review findings: a roadmap and lessons to be learned from ACCORD
  2. Tuning up the chords of consensus research with the ACcurate COnsensus Reporting Document (ACCORD)
  3. ACcurate COnsensus Reporting Document (ACCORD) explanation and elaboration: Guidance and examples to support reporting consensus methods
  4. Delayed Onset Type I Allergic Reaction Following Black Tattoo Removal Using Picosecond Laser
  5. Global Guidelines in Dermatology Mapping Project (GUIDEMAP)—A systematic review of the methodological quality of contact dermatitis clinical practice guidelines
  6. Rosacea
  7. ACCORD (ACcurate COnsensus Reporting Document): A reporting guideline for consensus methods in biomedicine developed via a modified Delphi
  8. Frequency and clinical relevance of contact allergy in dental patients
  9. The future is now: the Global Atopic Dermatitis Atlas (GADA)
  10. Guideline-based intervention improves the quality of antibiotic allergy registration in a hospital setting
  11. Existing guidance on reporting of consensus methodology: a systematic review to inform ACCORD guideline development
  12. ACCORD guideline for reporting consensus-based methods in biomedical research and clinical practice: a study protocol
  13. Network meta‐analysis: methodological points for readers, authors and reviewers
  14. Global Guidelines in Dermatology Mapping Project ( GUIDEMAP ), a systematic review of atopic dermatitis clinical practice guidelines: are they clear, unbiased, trustworthy and evidence based ( CUTE
  15. Contact allergy to a shellac‐containing mouthguard
  16. Gustatory Hyperhidrosis
  17. Rosacea treatments: Current standards and additional options
  18. Harmonizing Measurement of Satisfaction With Acne Scar Treatments: Can We All Sing the Same Tune?
  19. Rosacea: New Concepts in Classification and Treatment
  20. Identifying and appraising patient‐reported outcome measures on treatment satisfaction in acne: a systematic review*
  21. Publication of national dermatology guidelines as a Research Letter in the BJD : can less ever be enough?
  22. Rosacea treatment guideline for the Netherlands
  23. Consistency of Recommendations for Evaluation and Management of Hypertension
  24. Recommendations for rosacea diagnosis, classification and management: update from the global ROS acea CO nsensus 2019 panel
  25. Common methodological pitfalls and new developments in systematic review meta‐analyses
  26. Antibiotic use for irreversible pulpitis
  27. Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments
  28. Why does the BJD require registration of systematic reviews and meta-analyses?
  29. Effects of low-carbohydrate- compared with low-fat-diet interventions on metabolic control in people with type 2 diabetes: a systematic review including GRADE assessments
  30. Is there randomized controlled trial evidence to support the use of interventions for preventing occupational irritant hand dermatitis (OIHD)?
  31. A breathtaking DRESS due to amoxicillin-clavulanate presenting as polymorphic eruption of the pregnancy
  32. Light on fumaric acid esters therapy for psoriasis
  33. Palladium-induced granulomas analysed with inductively coupled plasma mass spectrometry
  34. AGREE II assessments of recent acne treatment guidelines: how well do they reveal trustworthiness as defined by the U.S. Institute of Medicine criteria?
  35. Rosacea
  36. Laser treatment of congenital melanocytic nevi: a systematic review
  37. Emollients and moisturizers for eczema: abridged Cochrane systematic review including GRADE assessments
  38. Introducing the new Evidence-Based Dermatology section
  39. Systematic reviews: let's keep them trustworthy
  40. News and Notices
  41. Performance and Tolerability of the Moisturizers Cetaphil® and Excipial® in Atopic Dermatitis: What is the Evidence Based on Randomized Trials?
  42. Interventions for Female Pattern Hair Loss
  43. Emollients and moisturisers for eczema
  44. Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review
  45. Rosacea treatment update: recommendations from the global ROS acea CO nsensus ( ROSCO ) panel
  46. Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROS acea CO nsensus ( ROSCO ) panel
  47. Epidermal growth factor receptor inhibitor-associated rash prevented by oral tetracyclines
  48. Shared decision making and patient decision aids in dermatology
  49. Moose on the loose: checklist for meta-analyses of observational studies
  50. Moose on the loose
  51. Which antibiotic is the most effective  in people with cellulitis and erysipelas?
  52. Prevalence and odds of Staphylococcus aureuscarriage in atopic dermatitis: a systematic review and meta-analysis
  53. Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review includingGRADEassessments
  54. 10.1007/s10096-016-2647-3
  55. 10.1016/j.jid.2016.03.003
  56. A systematic review and meta-analysis on Staphylococcus aureus carriage in psoriasis, acne and rosacea
  57. RAPADAPTE for rapid guideline development: high-quality clinical guidelines can be rapidly developed with limited resources
  58. Emollients and moisturisers for eczema
  59. Antibiotic use for irreversible pulpitis
  60. Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease
  61. Interventions for Rosacea
  62. Interventions for Hirsutism
  63. Day care versus in-patient surgery for age-related cataract
  64. Diphencyprone treatment in patients with alopecia areata
  65. Interventions for rosacea: abridged updated Cochrane systematic review including GRADE assessments
  66. Paleo systematic review
  67. Limitations in conduct and reporting of cochrane reviews rarely inhibit the determination of the validity of evidence for clinical decision-making
  68. Omalizumab in patients with chronic spontaneous urticaria: a systematic review and GRADE assessment
  69. Interventions for rosacea
  70. Interventions for hirsutism (excluding laser and photoepilation therapy alone)
  71. Interventions for skin reactions associated with targeted anticancer treatments
  72. Evidence-based topical treatments for tinea cruris and tinea corporis: a summary of a Cochrane systematic review
  73. Penicillin to prevent recurrent leg cellulitis: a critical appraisal
  74. Alpine climate treatment of atopic dermatitis: a systematic review
  75. Topical antifungal treatments for tinea cruris and tinea corporis
  76. Low-Molecular-Weight Heparins for Managing Vasoocclusive Crises in People With Sickle Cell Disease: A Summary of a Cochrane Systematic Review
  77. Selenium supplementation for Hashimoto’s thyroiditis
  78. Contact urticaria from beer
  79. Contact allergy to Tinosorb® M: recommendations for diagnostic improvement
  80. No high level evidence to support the use of oral H1 antihistamines as monotherapy for eczema: a summary of a Cochrane systematic review
  81. Antibiotic use for irreversible pulpitis
  82. Selenium Supplementation for Hashimoto's Thyroiditis: Summary of a Cochrane Systematic Review
  83. Efficacy of Topical Antifungal Agents in the Treatment of Dermatophytosis: An Incomplete Meta-Analysis
  84. Oral rinses, mouthwashes and sprays for improving recovery following tonsillectomy
  85. Botulinum toxin for masseter hypertrophy
  86. Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency in people with multiple sclerosis: a summary of a Cochrane systematic review
  87. Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease
  88. Selenium supplementation for Hashimoto's thyroiditis
  89. Oral H1 antihistamines as monotherapy for eczema
  90. Interventions for hirsutism excluding laser and photoepilation therapy
  91. 'Liberation procedure' for treatment of venous stenoses (CCSVI) in the brain of MS sufferers
  92. Selenium supplementation for Hashimoto's thyroiditis
  93. Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease
  94. Evidence-based treatments for female pattern hair loss: a summary of a Cochrane systematic review
  95. Lack of ‘appropriately assessed’ patient-reported outcomes in randomized controlled trials assessing the effectiveness of interventions for rosacea
  96. Interventions for female pattern hair loss
  97. Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patients
  98. Interventions for female pattern hair loss
  99. Beta2-adrenoceptor agonists for dysmenorrhoea
  100. Histamine H2-receptor antagonists for urticaria
  101. Effective and evidence‐based management strategies for rosacea: summary of a Cochrane systematic review
  102. Day care versus in-patient surgery for age-related cataract
  103. Interventions for skin reactions associated with targeted anticancer treatments
  104. Interventions for rosacea
  105. Anaphylaxis after consuming soy products in patients with birch pollinosis
  106. An unusual case of contact dermatitis to procaine
  107. Cutaneous Allergy Testing in Patients Suspected of an Allergic Reaction to Eye Medication
  108. Moet een recidiverende furunkel op de neus direct met antibiotica worden behandeld?
  109. Relevance of Positive Patch-Test Reactions to Fragrance Mix
  110. Systematic review of rosacea treatments
  111. Heeft de Diane-pil een gunstige invloed op rosacea?
  112. Kan ‘chirurgisch staal’ ook een allergie verooorzaken?
  113. Is het zinvol om bij toepassing van dermatologica bij eczeem te kiezen voor een wolvet-vrij vehiculum?
  114. Betekent een allergie voor acetylsalicylzuur ook een allergie voor andere NSAID’s?
  115. Anaphylaxis to patent blue during sentinel lymph node identification
  116. Interventions for rosacea
  117. Nieuwe topicale immunomodulatoren voor de behandeling van atopisch eczeem
  118. Immediate type hypersensitivity after injection of nadroparin (Fraxiparin)
  119. Evidence-Based Dermatology
  120. Interventions for rosacea
  121. Diffuse neurofibroma on the lower back
  122. Computer-related skin diseases
  123. Aleukaemic leukaemia cutis in a patient with acute T-cell lymphoblastic leukaemia
  124. Recalcitrant atopic dermatitis due to allergy to Compositae
  125. Psychosocial Impact of Acne vulgaris
  126. Interventions for acne rosacea
  127. Basal cell carcinoma on the dorsum of the hand: report of 11 cases
  128. Carcinoma of the lip in kidney transplant recipients
  129. Treatment of recurrent squamous cell carcinoma of the hand in immunonosuppressed patients
  130. Resurfacing the back of the hand as treatment and prevention of multiple skin cancers in kidney transplant recipients
  131. A randomized clinical trial to compare two different approaches in women with chronic pelvic pain